BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10826514)

  • 1. A study on the genetics of obesity: influence of polymorphisms of the beta-3-adrenergic receptor and insulin receptor substrate 1 in relation to weight loss, waist to hip ratio and frequencies of common cardiovascular risk factors.
    Benecke H; Topak H; von zur Mühlen A; Schuppert F
    Exp Clin Endocrinol Diabetes; 2000; 108(2):86-92. PubMed ID: 10826514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.
    Widén E; Lehto M; Kanninen T; Walston J; Shuldiner AR; Groop LC
    N Engl J Med; 1995 Aug; 333(6):348-51. PubMed ID: 7609751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms of insulin receptor substrate 1 and beta3-adrenergic receptor genes in gestational diabetes and normal pregnancy.
    Fallucca F; Dalfrà MG; Sciullo E; Masin M; Buongiorno AM; Napoli A; Fedele D; Lapolla A
    Metabolism; 2006 Nov; 55(11):1451-6. PubMed ID: 17046546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common amino acid substitutions in insulin receptor substrate-4 are not associated with Type II diabetes mellitus or insulin resistance.
    Almind K; Frederiksen SK; Ahlgren MG; Urhammer S; Hansen T; Clausen JO; Pedersen O
    Diabetologia; 1998 Aug; 41(8):969-74. PubMed ID: 9726601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UKPDS 19: heterogeneity in NIDDM: separate contributions of IRS-1 and beta 3-adrenergic-receptor mutations to insulin resistance and obesity respectively with no evidence for glycogen synthase gene mutations. UK Prospective Diabetes Study.
    Zhang Y; Wat N; Stratton IM; Warren-Perry MG; Orho M; Groop L; Turner RC
    Diabetologia; 1996 Dec; 39(12):1505-11. PubMed ID: 8960833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin receptor substrate-1 Gly972Arg polymorphism is not associated with Type 2 diabetes mellitus in two population-based studies.
    van Dam RM; Hoebee B; Seidell JC; Schaap MM; Blaak EE; Feskens EJ
    Diabet Med; 2004 Jul; 21(7):752-8. PubMed ID: 15209769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular risk factors in obese women and their first-degree relatives.
    Saraç F; Ozgen AG; Yilmaz C; Tüzün M
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):371-7. PubMed ID: 18065331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation of Trp64Arg polymorphism of beta 3-adrenergic receptor gene to adipocytokines and fat distribution in obese patients.
    de Luis DA; Aller R; Izaola O; Gonzalez Sagrado M; Conde R
    Ann Nutr Metab; 2008; 52(4):267-71. PubMed ID: 18617734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymorphism analysis of candidate genes for type 2 diabetes mellitus in a Mexican ethnic group.
    Flores-Martínez SE; Islas-Andrade S; Machorro-Lazo MV; Revilla MC; Juárez RE; Mújica-López KI; Morán-Moguel MC; López-Cardona MG; Sánchez-Corona J
    Ann Genet; 2004; 47(4):339-48. PubMed ID: 15581831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta(2)-adrenergic receptor mutation and abdominal obesity risk: effect modification by gender and HDL-cholesterol.
    Corbalán MS; Marti A; Forga L; Martínez-González MA; Martínez JA
    Eur J Nutr; 2002 Jun; 41(3):114-8. PubMed ID: 12111048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Trp64Arg polymorphism of beta 3-adrenoreceptor gene on insulin resistance, adipocytokines and weight loss secondary to two hypocaloric diets.
    de Luis DA; González Sagrado M; Aller R; Izaola O; Conde R
    Ann Nutr Metab; 2009; 54(2):104-10. PubMed ID: 19295193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association between the Trp64Arg polymorphism in the beta3-adrenergic receptor gene and endometrial cancer and obesity.
    Babol K; Przybylowska K; Lukaszek M; Pertynski T; Blasiak J
    J Exp Clin Cancer Res; 2004 Dec; 23(4):669-74. PubMed ID: 15743038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulty in losing weight by behavioral intervention for women with Trp64Arg polymorphism of the beta3-adrenergic receptor gene.
    Shiwaku K; Nogi A; Anuurad E; Kitajima K; Enkhmaa B; Shimono K; Yamane Y
    Int J Obes Relat Metab Disord; 2003 Sep; 27(9):1028-36. PubMed ID: 12917707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene.
    Walston J; Silver K; Bogardus C; Knowler WC; Celi FS; Austin S; Manning B; Strosberg AD; Stern MP; Raben N
    N Engl J Med; 1995 Aug; 333(6):343-7. PubMed ID: 7609750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of insulin resistance.
    Pedersen O
    Exp Clin Endocrinol Diabetes; 1999; 107(2):113-8. PubMed ID: 10320051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians.
    Bodhini D; Radha V; Deepa R; Ghosh S; Majumder PP; Rao MR; Mohan V
    Int J Obes (Lond); 2007 Jan; 31(1):97-102. PubMed ID: 16652127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of polymorphism the Gly972Arg variant insulin receptor substrate-1 (IRS-1) gene, and G-308A TNF-alpha gene on obesity and insulin resistance in children with obesity].
    Pyrzak B; Wiśniewska A; Rymkiewicz-Kluczyńska B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):175-8. PubMed ID: 17020651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism of the beta 3-adrenergic receptor gene in morbid obesity.
    Oksanen L; Mustajoki P; Kaprio J; Kainulainen K; Jänne O; Peltonen L; Kontula K
    Int J Obes Relat Metab Disord; 1996 Dec; 20(12):1055-61. PubMed ID: 8968849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the benefits of moderate weight loss?
    de Leiva A
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 2():10-3. PubMed ID: 9792475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.